Furthermore, inhibition of CXCR4 by AMD3100 mobilizes tumor cells out of the BM and leads to increased chemosensitivity, although the effect of this treatment on the cell cycle remains to be determined [7]. This evidence concerns the gene CXCR4 and neoplasm.